[ad_1]
AstraZeneca has announced that its vaccine would be effective against the new variant of the coronavirus
The announcement of a new mutation of Sars-CoV-2, at the dawn of the vaccination campaign expected around the world to end the pandemic, has sparked a wave of concern and despair. Although experts have been very cautious in discussing the impact this English variant may have on the vaccine, they generally agree that there is no evidence of potential ineffectiveness.
Covid vaccine, AstraZeneca ad: “Effective against new variant”
The company AstraZeneca, whose coronavirus vaccine, the so-called European vaccine, is among the top candidates alongside those of Pfizer and Moderna, has taken a stand. According to The Guardian, AstraZeneca said its vaccine would be effective against the new variant of Sars-CoV-2.
A company spokesperson said: “AZD1222 (AstraZeneca vaccine) contains the genetic material of protein spike the coronavirus and the changes in the genetic code observed in this new viral strain do not seem to modify the structure of the peak protein ”.
Pfizer vaccine, Aifa ok: when to start
Meanwhile, the EMA, and immediately after Aifa, have authorized the distribution and administration in Europe and Italy of the Pfizer-Biontech vaccine, in time for the celebration of the European V-Day on December 27. Apart from the announcement, the president of Aifa, Giorgio Palù, also provided comforting news about the effects of the vaccine: it seems that the drug, in addition to blocking the infection, also makes the individual unable to transmit the infection. virus.
As for the Moderna vaccine, however, approval from the EMA is expected on January 6.
VIRGILIO NEWS | 12-23-2020 07:00
Photo source: ANSA
[ad_2]
